CTOs on the Move

GW Pharmaceuticals

www.gwpharm.com

 
GW was co-founded in 1998 by Dr. Geoffrey Guy and Dr. Brian Whittle, two well-known entrepreneurs in the UK biotech sector. In setting up GW, Drs. Guy and Whittle worked closely with both the UK Home Office and the UK`s medicines regulatory authority on establishing necessary licences and procedures so as to facilitate the progress of GW`s cannabinoid research program.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.gwpharm.com
  • 5750 Fleet Street Suite 200
    Carlsbad, CA USA 92008
  • Phone: 760.795.2200

Executives

Name Title Contact Details

Similar Companies

Cabrellis

Cabrellis is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RxHub

RxHub LLC is a Saint Paul, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Legacy Pharmaceuticals International

Legacy Pharmaceuticals International is a Humacao, PR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Edenbridge Pharmaceuticals

Vera Therapeutics

Vera Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera`s lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator (BLyS) and a proliferation-inducing ligand (APRIL), which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases. In addition, Vera is evaluating additional diseases where the reduction of autoantibodies by atacicept may prove medically useful, including lupus nephritis, a severe renal manifestation of systemic lupus erythematosus.